Search Results for: Chugai
Interviews BioJapanJapan
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Oct 8-Oct 13
2023-10-17
Feature Chugai PharmaceuticalBioJapancollaborationAsia
Building Bridges at the Brand-New Chugai Life Science Park
2023-10-10
Trials & Approvals Hemophilia A
Sanofi’s Treatment for Hemophilia A has a Concrete FDA Decision Date
2022-08-30
Special South Korea
Korean Companies Occupying South Korea’s Diverse Biotech Landscape
2022-08-03
Biomanufacturing
Japan’s Chugai Infuses $500 Million for a New API Manufacturing Building
2021-07-29
COVID-19 Vaccine
Japan’s Shionogi to Provide 120 Million Doses of COVID-19 Vaccines Annually
2021-07-08
Trials & Approvals Gene Therapy
Pfizer, Sangamo Dose First Hemophilia A Patient in Phase 3 with Gene Therapy Candidate
2020-10-08
COVID-19 Remdesivir
Remdesivir’s Early Trial Data Necessitates Guarded Optimism
2020-04-12
COVID-19 Japan
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
FDA
Weekly Cover：Foundation Medicine and Chugai Partnership with National Cancer Center
2020-02-18
COVID-19
Weekly Cover: Expansion of Samsung Biologics Projects into U.S. and Europe
2020-02-11
Trials & Approvals NK Cell
Weekly Cover: Acepodia’s NK Cell Therapy Drug Candidate ACE1702 Receives FDA Clearance of IND
2020-01-15
PD-1 Inhibitor
Weekly in Asia｜Nov-3
2019-12-03
Asia-Pacific BeiGene
Weekly in Asia｜Nov
2019-11-07
1 2
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top